News 2020

  • 22.03.2020
    News for the Industry
    If you want to find about the new regulatory requirements in Europe and USA, we recommend the following websites to you:  Europe EMA: a) ... More
  • 23.03.2020
    In-house Trainings and Webinars
    NEW!  We now offer all our in-house trainings also as tailor-made webinars. Interaction between you and the speaker is possible, since you can choose from different ... More
  • 24.03.2020
    News on Nitrosamine Impurities
    Risk evaluation needed for all APIs until 26.03.2020! Have you finalized your risk assessment for all your APIs and sent to the Authorities in time? Do you know what's coming next and where to ... More
  • 26.03.2020
    New Deadline for Nitrosamine Impurities
    Risk Evaluation: Extension of Deadline for CEP-Holders until 31.July 20 and for MAH (Marketing Authorisation Holders) until 1.October 2020 The deadline of 26.03.20 to complete step 1 ... More
  • 18.05.2020
    Impact of COVID-19 pandemic on Pharma: GMP and Regulatory Flexibility
    Are you aware that a few measures were introduced to ensure the supply chain during COVID-19 pandemic? This enables the MAH to act quickly and provides regulatory relief. Here are a few ... More
  • 29.10.2020
    Latest Guidances regarding Nitrosamine Impurities
    Are you aware of the latest news on Nitrosamines in Europe and US? Do you know the details and deadlines? HORN Pharmaceutical Consulting is glad to help you find out more. 1.Situation in ... More


Phone +49 (0) 7251/305 529
Fax +49 (0) 7251/305 528


  • 18.-19.06.2024
    Online Seminar: Der Regulatory Affairs Manager
Get all events


  • 19.12.2022
    EU Update regarding Deadlines of Nitrosamine Impurities
  • 01.09.2022
    EU-GMP Annex 1 finally published
  • 26.08.2022
    New Deadlines and Chances for Nitrosamines
Get all news